Spanish native Enrique Álvarez gives an overview of Denmark’s importance to Merck as a key European early launch market, a crucial clinical trial destination, and home to a treasure trove of holistic patient data. Álvarez also outlines the increasing challenges around market access in the country and his talent development and retention strategy.
COVID-19 has reaffirmed the importance of public-private partnerships within Danish healthcare, and we are seeing an increasing willingness from universities, hospitals, the Danish regions, and governmental agencies to initiate and embark upon collaborations with the private sector
